2021-01-13, <Research Report>Macquarie Adds BEIGENE (06160.HK) TP to $101.46; Rated Underperform 
2021-01-13, *Macquarie Adds BEIGENE (06160.HK) TP to $101.46; Rated Underperform 
2020-12-15,   《HKEx》- 06160 BEIGENE - INSIDE INFORMATION -  COLLABORATION WITH NOVARTIS TO DEVELOP AND COMMERCIALIZE ANTI-PD-1 ANTIBODY TISLELIZUMAB 
2020-12-03,   《HKEx》- 06160 BEIGENE - OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K 
